|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 5, 2004
Professor of Gynaecological Oncology, Director of Cancer Institute, Barts & The London, QM School of Medicine, Gynaecological Cancer Unit, London EC1M 6GR
Corresponding Author: i.j.jacobs{at}qmul.ac.uk
none
Revised on February 5, 2004
Accepted on February 5, 2004
Progress & challenges in screening for early detection of ovarian cancer
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. R. Zachariah, S. Schmid, N. Buerki, R. Radpour, W. Holzgreve, and X. Zhong Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors Obstet. Gynecol., October 1, 2008; 112(4): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Drapkin, A. Clauss, and S. Skates Urokinase-Type Plasminogen Activator Receptor: A Beacon of Malignancy? Clin. Cancer Res., September 15, 2008; 14(18): 5643 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Visintin, Z. Feng, G. Longton, D. C. Ward, A. B. Alvero, Y. Lai, J. Tenthorey, A. Leiser, R. Flores-Saaib, H. Yu, et al. Diagnostic Markers for Early Detection of Ovarian Cancer Clin. Cancer Res., February 15, 2008; 14(4): 1065 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Moore and R. C. Bast Jr How Do You Distinguish a Malignant Pelvic Mass From a Benign Pelvic Mass? Imaging, Biomarkers, or None of the Above J. Clin. Oncol., September 20, 2007; 25(27): 4159 - 4161. [Full Text] [PDF] |
||||
![]() |
A. Barua, J. S. Abramowicz, J. M. Bahr, P. Bitterman, A. Dirks, K. A. Holub, E. Sheiner, M. J. Bradaric, S. L. Edassery, and J. L. Luborsky Detection of Ovarian Tumors in Chicken by Sonography: A Step Toward Early Diagnosis in Humans? J. Ultrasound Med., July 1, 2007; 26(7): 909 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B.J. Hermsen, S. von Mensdorff-Pouilly, J. Berkhof, P. J. van Diest, J. J.P. Gille, F. H. Menko, M. A. Blankenstein, P. Kenemans, and R. H.M. Verheijen Serum CA-125 in Relation to Adnexal Dysplasia and Cancer in Women at Hereditary High Risk of Ovarian Cancer J. Clin. Oncol., April 10, 2007; 25(11): 1383 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Scholler, M. Crawford, A. Sato, C. W. Drescher, K. C. O'Briant, N. Kiviat, G. L. Anderson, and N. Urban Bead-based ELISA for validation of ovarian cancer early detection markers. Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2117 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moscova, D. J. Marsh, and R. C. Baxter Protein Chip Discovery of Secreted Proteins Regulated by the Phosphatidylinositol 3-Kinase Pathway in Ovarian Cancer Cell Lines Cancer Res., February 1, 2006; 66(3): 1376 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Chambers and B. C. Vanderhyden Ovarian Cancer Biomarkers in Urine Clin. Cancer Res., January 15, 2006; 12(2): 323 - 327. [Full Text] [PDF] |
||||
![]() |
I. Jacobs Screening for Familial Ovarian Cancer: The Need for Well-Designed Prospective Studies J. Clin. Oncol., August 20, 2005; 23(24): 5443 - 5445. [Full Text] [PDF] |
||||
![]() |
G. Mor, I. Visintin, Y. Lai, H. Zhao, P. Schwartz, T. Rutherford, L. Yue, P. Bray-Ward, and D. C. Ward Serum protein markers for early detection of ovarian cancer PNAS, May 24, 2005; 102(21): 7677 - 7682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |